New ultrasound technique could spot brain disorders in babies before symptoms appear

NCT ID NCT06940713

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

The CONEXUS study is testing a new type of brain imaging called functional ultrasound (fUS) in 76 newborns at high risk for neurodevelopmental disorders. The technique uses sound waves to measure blood flow changes in the brain, similar to a regular ultrasound but more advanced. Researchers want to see if this painless, bedside scan can detect early signs of conditions like autism or cerebral palsy, potentially allowing doctors to start treatment sooner.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

functional ultrasound imaging (fUS) device

What this could lead to

If successful, this could provide a new, non-invasive way to detect early signs of neurodevelopmental disorders in newborns, enabling earlier treatment.

What could go wrong

This is an early feasibility study with only 76 participants, so results may not apply broadly. The technique may not reliably predict disorders, and technical challenges like motion artifacts could limit success.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEONATES AND PRETERM INFANTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

fetal growth restriction perinatal asphyxia Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hôpital Robert Debré

    RECRUITING

    Paris, 75019, France

    Contact